Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
One GLP-1RA, liraglutide, has been approved to treat obesity, and another, semaglutide, is in clinical trials
[10] There's no established drug interaction between standard probiotic strains and semaglutide or other GLP-1 receptor agonists
Be Part of Our Mission: Help us reach more people who can benefit from our services and support
Researchers recognised that at controlled doses, the glucose-lowering properties could be harnessed for medical benefit
Discontinue use and consult a healthcare provider if you experience persistent or concerning symptoms
US$ 20.43
US$ 25.13
US$ 26.28
